November 2021

Todos Medical Announces Second Clinical Trial Site for Phase 2 Clinical Trial of Tollovir for the Treatment of Patients Hospitalized by Covid-19

§ Phase 2 Interim Clinical Trial Expected in fourth quarter of 21 § Nature Neuroscience and Cell Reports Highlight Complementary Mechanisms of Viral Replication and Immunosuppression of 3CLpro (Mpro) New York, NY and Tel Aviv, ISRAEL, November 1, 2021 (GLOBE NEWSWIRE) – NewMediaWire – All Medical, Ltd. (OTCQB: TOMDF), a leading medical diagnostics and theranosis response company, today announced the addition of Hillel Yaffe Medical Center as a clinical trial site for now.

Todos Medical Announces Second Clinical Trial Site for Phase 2 Clinical Trial of Tollovir for the Treatment of Patients Hospitalized by Covid-19 Read More »